IP Library › Assignment 058957/0210
Patent Assignment
Reel/Frame 058957/0210

Change of Name

Recorded: 2022-02-04 Pages: 5
Assignor
ADARE DEVELOPMENT I, L.P.
Executed: 2019-11-25
Assignee
ADARE PHARMACEUTICALS US, LP
1200 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NEW JERSEY, 08648
Covered Property (1)
Orally Administered Corticosteroid Compositions
Application: 17/569,047 →
Publication: US 2022/0339098
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 4, 2022
From: PERRETT, STEPHEN; COHEN, FREDRIC JAY; VENKATESH, GOPI
To: EURAND, INC.
Reel/Frame 058888/0668 →
Assignment of Assignor's Interest Feb 4, 2022
From: ADARE PHARMACEUTICALS, INC.
To: ADARE DEVELOPMENT, I L.P.
Reel/Frame 058888/0812 →
Change of Name Feb 4, 2022
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 058956/0679 →
Change of Name Feb 4, 2022
From: ADARE PHARMACEUTICALS US, L.P.
To: ELLODI PHARMACEUTICALS, L.P.
Reel/Frame 058957/0658 →
Change of Name Feb 4, 2022
From: EURAND, INCORPORATED
To: APTALIS PHARMATECH, INC.
Reel/Frame 058959/0338 →